Company / Gross Profit per Share
Neogen Gross Profit per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.95
FY2024
5-year range
$1.95 / $4.30
FY2020-FY2024
Trend
-54.7%
vs FY2023
Sector context
#88 of 94
Health Care
What the data says
Among 94 Health Care companies, Neogen is in the bottom 6% for gross profit per share. Gross Profit per Share has fluctuated over the past 9 years, ranging from $1.95 in FY2024 to $4.96 in FY2017.
Based on SEC 10-K filings.
1.95 in FY2024 with a 5-year CAGR of -12.5%.
Declined from $3.78 to $1.95 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -5.3%
- 5-Year CAGR
- -12.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 94This company $1.95 Sector average $14.29
▼
-86.4% below sector average
Key checks
Key Insights
- In FY2024, gross profit per share decreased 54.7% year-over-year.
- Ranks #88 out of 94 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.95 | -54.7% |
| FY2023 | $4.30 | +13.9% |
| FY2022 | $3.78 | +64.6% |
| FY2021 | $2.29 | -44.3% |
| FY2020 | $4.12 | +8.6% |
| FY2019 | $3.79 | +0.7% |
| FY2018 | $3.77 | -24.0% |
| FY2017 | $4.96 | +9.0% |
| FY2016 | $4.55 | +9.2% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026